The PE Ratio as of December 2024 (TTM) for Fusion Pharmaceuticals Inc. (FUSN) is -15.39

According to Fusion Pharmaceuticals Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -15.39. This represents a change of 145.06% compared to the average of -6.28 of the last 4 quarters.

Fusion Pharmaceuticals Inc. (FUSN) Historical PE Ratio (quarterly & annually)

How has FUSN PE Ratio performed in the past?

The mean historical PE Ratio of Fusion Pharmaceuticals Inc. over the last ten years is -36.46. The current -15.39 PE Ratio has changed 4.12% with respect to the historical average. Over the past ten years (40 quarters), FUSN's PE Ratio was at its highest in in the June 2020 quarter at -0.23. The PE Ratio was at its lowest in in the September 2019 quarter at -152.42.

Fusion Pharmaceuticals Inc. (FUSN) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Fusion Pharmaceuticals Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Fusion Pharmaceuticals Inc. (FUSN) Average PE Ratio

How has FUSN PE Ratio performed in the past?

The current PE Ratio of Fusion Pharmaceuticals Inc. (FUSN) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Fusion Pharmaceuticals Inc. (FUSN) PE Ratio vs. Peers

How is FUSN’s PE Ratio compared to its peers?

Fusion Pharmaceuticals Inc.’s PE Ratio is less than Bicycle Therapeutics plc (-6.09), less than Relmada Therapeutics, Inc. (-0.13), less than RAPT Therapeutics, Inc. (-0.63), less than NewAmsterdam Pharma Company N.V. (-13.47), less than BioAtla, Inc. (-0.37), less than Passage Bio, Inc. (-0.58), less than PMV Pharmaceuticals, Inc. (-1.47), less than Ikena Oncology, Inc. (-1.24), less than Olema Pharmaceuticals, Inc. (-2.95), less than Spero Therapeutics, Inc. (17.30), less than Bolt Biotherapeutics, Inc. (-0.30), greater than Coherus BioSciences, Inc. (-376.35), greater than Gracell Biotechnologies Inc. (-29.26), less than Neoleukin Therapeutics, Inc. (-5.86), less than Keros Therapeutics, Inc. (-3.32), greater than Janux Therapeutics, Inc. (-50.66), greater than Fennec Pharmaceuticals Inc. (-140.49), greater than Edgewise Therapeutics, Inc. (-22.36), less than Harmony Biosciences Holdings, Inc. (15.80),

Build a custom stock screener for Fusion Pharmaceuticals Inc. (FUSN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Fusion Pharmaceuticals Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Fusion Pharmaceuticals Inc. (FUSN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Fusion Pharmaceuticals Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.